Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PZ HTL SA

New Tool Developed to Identify Genetic Risk Factors

By BiotechDaily International staff writers
Posted on 13 Feb 2014
Image: Pathway-based Human Phenotype Network classification shows relationships between diseases and traits based on shared etiology for certain phenotypes. The diseases and traits in these clusters have more connections to each other than to others in the network: the bolder the line, the stronger the connection (Photo courtesy of Dartmouth College).
Image: Pathway-based Human Phenotype Network classification shows relationships between diseases and traits based on shared etiology for certain phenotypes. The diseases and traits in these clusters have more connections to each other than to others in the network: the bolder the line, the stronger the connection (Photo courtesy of Dartmouth College).
A new biological pathway-based computational model has been developed to identify underlying genetic connections between different diseases.

The model called the Pathway-based Human Phenotype Network (PHPN) mines the data present in large publicly available disease datasets to find shared single nucleotide polymorphisms (SNPs), genes, or pathways and expresses them in a visual form.

Geneticists at the Geisel School of Medicine at Dartmouth (Hanover, NH, USA) built a pathway-based human phenotype network (PHPN) of over 800 physical attributes, diseases, and behavioral traits, based on about 2,300 genes and 1,200 biological pathways. Using genome-wide association study (GWAS) phenotype-to-genes associations, and pathway data from a free, open-source, curated and peer reviewed pathway database Reactome, they connected human traits based on the common patterns of human biological pathways, detecting more pleiotropic effects, and expanding previous studies from a gene-centric approach to that of shared cell-processes.

PHPN supports the integration of genomic and phenotypic data to uncover significant links between traits, attributes, and disease. This offers tremendous potential in identifying risk factors for certain diseases. At the same time, it can reveal important targets for therapeutic intervention. The automatic classification of phenotypes into “phenotype classes,” using the network’s topological modularity and a standard community detection algorithm, showed very promising results. Two traits that were connected in the PHPN but did not share any common associated genes or any clear-cut biological relationship were von Willebrand factor and FVIII levels (vWF) and hippocampal atrophy (HA).

Christian Darabos, PhD, the lead author of the study, said, “The intuitive network representation of the knowledge mined from several large-scale datasets makes the information accessible to anyone. It lies at the crossroads of computational genetics, systems biology, information theory, and network science. As a proof of concept, the PHPN has proven capable of identifying well-documented interactions, and many novel links that remain to be explored in depth. The PHPN is a hypothesis-generating tool, potentially capable of identifying yet uncharacterized common drug targets.” As a next step, the scientists will refine statistical methods, isolate networks for optimal results, and compare previous work on phenotype networks. The study was published on January 25, 2014, in the journal BioDataMining.

Related Links:

Geisel School of Medicine at Dartmouth
Reactome



BIOSIGMA S.R.L.
RANDOX LABORATORIES
SLAS - Society for Laboratory Automation and Screening
comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: A 3-dimensional picture reveals how the antibodies in the experimental drug Zmapp bind to Ebola virus (Photo courtesy of the Scripps Research Institute).

Electron Microscope Imaging Shows How Experimental Anti-Ebola Drug Works

Electron microscope imaging has revealed how the experimental drug ZMapp binds to the Ebolavirus and provides insights into how the drug prevents growth of the pathogen. ZMapp, which was developed by... Read more

Drug Discovery

view channel

Omega 3 Found to Improve Behavior in Children with ADHD

Supplements of the fatty acids omega 3 and 6 can help children and adolescents who have a specific kind of have attention deficit hyperactivity disorder (ADHD). Moreover, these findings indicate that a customized cognitive training program can improve problem behavior in children with ADHD. Statistics show that 3%–6%... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Lab Technologies

view channel

e-Incubator Technology Provides Real-Time Imaging of Bioengineered Tissues in a Controlled Unit

A new e-incubator, an innovative miniature incubator that is compatible with magnetic resonance imaging (MRI), enables scientists to grow tissue-engineered constructs under a controlled setting and to study their growth and development in real time without risk of contamination or damage. Offering the potential to test... Read more

Business

view channel

Two Industry Partnerships Initiated to Fuel Neuroscience Research

Faster, more complex neural research is now attainable by combining technology from two research companies. Blackrock Microsystems, LLC (Salt Lake City, UT, USA), a developer of neuroscience research equipment, announced partnerships with two neuroscience research firms—PhenoSys, GmbH (Berlin, Germany) and NAN Instruments, Ltd.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.